Market Tracker

08/27 5:16pm ET

Repligen Corp (NASDAQ:RGEN)

During the Trading Day
34.38 +0.59 / +1.75%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
34.38 0.00 / 0.00%
 
Volume: 20.6K

Today’s Trading

Previous close33.79
Today’s open34.23
Day’s range33.09 - 34.43
Volume312,854
Average volume (3 months)349,050
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+34.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio151.7
Price/Sales10.36
Price/Book9.91

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...+3.37+13.73%
MACKMerrimack Pharmaceut...+0.34+3.37%
ZIOPZIOPHARM Oncology In...+0.27+3.21%
CLLSCellectis SA+2.18+7.14%
Data as of 3:59pm ET, 08/27/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$0.07
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts